domenica, 3 maggio 2026

Notizie AIOM – anno XVII

8 Febbraio 2019

Dal Soroptimist International Club Genova a favore delle ragazze STEM

Il Premio, del valore di 2.000 Euro, sarà attribuito ad una Tesi di Laurea Magistrale in campo Emato-Oncologico, discussa da una studentessa dell’Università degli Studi di Genova negli anni accademici 2016-17 o 2017-18, in una delle seguenti discipline: ...
Leggi tutto

8 Febbraio 2019

Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial

There is no recommended therapy for malignant pleural mesothelioma that has progressed after first-line pemetrexed and platinum-based chemotherapy. Disease control has been less than 30% in all previous studies of second-line drugs. Preliminary results have suggested that ...
Leggi tutto

8 Febbraio 2019

A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy

E-cigarettes are commonly used in attempts to stop smoking, but evidence is limited regarding their effectiveness as compared with that of nicotine products approved as smoking-cessation treatments. We randomly assigned adults attending U.K. National Health Service stop-smoking ...
Leggi tutto

8 Febbraio 2019

4 febbraio 2019 – Comunicazione EMA sul rischio di sanguinamento associato agli anticoagulanti orali ad azione diretta

8 Febbraio 2019

6 febbraio 2019 – Comitato per i Medicinali per Uso umano (CHMP) dell’EMA: highlights del meeting di gennaio

8 Febbraio 2019

World Cancer Day 2019: Emphasis on Early Detection

February 4, 2019 - World Cancer Day 2019 -February 4- highlights the need for urgent action to increase early-stage cancer detection, screening, and diagnosis to significantly improve patients’ chances of survival. Taking place with the theme of “I Am and I Will,” ...
Leggi tutto

8 Febbraio 2019

More Than 60 Leading Health-Care Organizations Call on CMS to Maintain Coverage for Medically Necessary Cancer Testing

February 7, 2019 - Leading health-care companies and organizations representing patients, providers, academic medical centers, laboratories, and diagnostic manufacturers urged the Centers for Medicare & Medicaid Services (CMS) to revise its interpretation of the National ...
Leggi tutto

8 Febbraio 2019

FDA Grants Priority Review to Pexidartinib for Tenosynovial Giant Cell Tumor

February 5, 2019 - The FDA has granted a priority review designation to a new drug application (NDA) for the investigational, small molecule, CSF1R receptor inhibitor pexidartinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT). ...
Leggi tutto

8 Febbraio 2019

Statement from Binita Ashar, M.D., of the FDA’s Center for Devices and Radiological Health on agency’s continuing efforts to educate patients on known risk of lymphoma from breast implants

February 6, 2019 - One of the most important roles we have as a public health agency is educating patients and health care providers about both the benefits and risks of medical products, including breast implants. I know there are many choices of breast implants available ...
Leggi tutto

8 Febbraio 2019

FDA Schedules ODAC Meeting for Selinexor in Penta-Refractory Myeloma

February 7, 2019 - The FDA has scheduled an Oncologic Drugs Advisory Committee (ODAC) hearing for February 26, 2019, to discuss a new drug application (NDA) for selinexor in combination with dexamethasone for the treatment of patients with penta-refractory multiple myeloma. ...
Leggi tutto